Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00313820Phase 4Completed
Phase 4, randomised, double-blind trial in central poststroke pain (CPSP) comparing Pregabalin with Placebo (2 arms). Primary endpoint: Mean Pain Score at Endpoint as Measured by Daily Pain Rating Scale at 12 weeks. Started Aug 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00313820.